期刊文献+

硝酸布康唑栓的人体药代动力学 被引量:1

Pharmacokinetics of butoconazole nitrate suppositories in human
下载PDF
导出
摘要 研究单次及多次阴道给药后硝酸布康唑栓在中国健康女性体内的药代动力学特征。12名健康女性受试者依次进行硝酸布康唑栓低(0.05g)、高(0.1g)剂量单次给药以及高剂量(0.1g)连续给药3d和连续给药5d药代动力学试验。受试者单次阴道给予0.05和0.1g受试制剂后,布康唑的Cmax分别为(0.8950±0.2610)、(1.740±0.511)ng/mL,AUC0-96h分别为(36.38±10.82)、(73.48±28.99)ng·h/mL,t1/2分别为(23.0±4.4)、(21.5±5.9)h。结果表明:布康唑在0.05—0.1g剂量范围内呈线性药代动力学特征。受试者连续3d给予硝酸布康唑栓后,布康唑的血药浓度波动度(DF)为(0.54±0.27),累积常数Rcmax为(1.3±0.3),RAUC0-τ为(1.4±0.3)。连续给药5d后,布康唑的血药浓度DF为(0.64±0.25),累积常数Rcmax为(1.4±0.3),RAUC0-τ,为(1.6±0.2),在人体内的暴露量增加约60%。连续给药3d与连续给药5d的各项药动学参数均无显著性差异。 The aim of the study was to investigate the pharmacokinetics of butoconazole nitrate suppositories in healthy Chinese female volunteers after single and multiple-dose vaginal administration. 12 healthy Chinese female volunteers received single 0. 05 g, single 0. 1 g, multiple doses (0. 1 g per day, 3-day consecutive adminis- tration) and multiple doses (0. 1 g per day, 5-day consecutive administration) of butoconazole nitrate suppositories. For 0. 05 g and 0. 1 g single vaginal administration of butoconazole nitrate suppositories, the Cmax were(0. 895 0 ±0. 261 0)and( 1. 740± 0. 511) ng/mL and the AUC0-96 h were( 36. 38 ± 10. 82) and( 73.48 ± 28.99) ng. h/mL, respectively. In the range of 0.05-0. 1 g, butoconazole demonstrated linear pharmacokinetics. In the multiple- dose study at 0. 1 g dose for 3 consecutive days, the degree of fluctuation (DF) was (0. 54 ± 0. 27), and the accu- mulation parameters Rcmax and RAuc0-τ were ( 1.3±0.3) and ( 1.4±0. 3), respectively. In the multiple-dose study at 0. 1 g dose for 5 consecutive days, the DF was (0. 64 ± 0. 25), and the accumulation parameter Rcmax and RAUc were ( 1.4 ± 0.3) ) and ( 1.6 ± 0.2), respectively. An accumulation of 60% in AUC0-τ, occurred after a multiple administration. The main pharmacokinetic parameters between 3-day consecutive administration and 5-day consecutive administration showed no significant difference.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2013年第6期548-552,共5页 Journal of China Pharmaceutical University
关键词 硝酸布康唑 栓剂 LC—MS 多次给药 药代动力学 阴道给药 butoconazole nitrate suppository LC-MS multiple dose administration pharmacokinetics vaginal administration
  • 相关文献

参考文献1

二级参考文献14

  • 1黄荻,丁莉坤,丁黎,徐贵丽,贺建昌.LC-MS法测定人血浆中赖诺普利及其在药代动力学中的应用[J].中国药科大学学报,2006,37(5):428-431. 被引量:7
  • 2丁莉坤,周霞,丁黎,杨林,文爱东.甲磺司特活性代谢物M-1的人体药代动力学[J].中国药科大学学报,2007,38(2):153-156. 被引量:1
  • 3Kouchi Y, Maeda Y, Ohuchida A, et al. Potassium oxonate modulation of 5-fluorouracil-indueed myelotoxicity in murine and human colony forming assays of hematopoietic precursor cells [ J ]. Toxicol Lett,2002,135 ( 1/2 ) : 11 - 18.
  • 4Kouchi M, Fnjii M, Kanamori N, et al. Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients [ J ]. Cancer Chemother Pharmacol, 2007,60 ( 5 ) :693 - 701.
  • 5Van Groeningen C J, Peters GJ, Schornagel JH, et al. Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors[J]. J Clin Oncol,2000,18(14) :2 772 - 2 779.
  • 6Kitamura R, Satoh T, Maeda M, et al. Enzyme immunoassay of potassium oxonate using specific antibody isolated by immunosorbent gel [ J ]. Yakugaku Zasshi, 1994,114 ( 3 ) : 171 - 175.
  • 7Matsushima E, Yoshida K, Kitamura R, et al. Determination of S- 1 ( combined drug of tegafur), 5-chloro-2,4-dihydroxypyridine and potassium oxonate and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry[ J]. J Chromatogr B, 1997,691 ( 1 ) :95 - 104.
  • 8Liu K, Zhong D, Zou H, et al. Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry [ J ]. J Pharm Biomed Anal, 2010,52(4) :550 -556.
  • 9Hoff PM, Saad ED, Ajani JA, et al. Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors [ J ]. Clin Can Res,2003,9 ( 1 ) : 134 - 142.
  • 10Cohen SJ,Leichman CG,Yeslow G,et al. Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer[ J ]. Clin Can Res, 2002,8 (7) : 2 116 - 2 222.

共引文献14

同被引文献11

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部